TRIMBLE INC. (TRMB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-02. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 1.5B 3B 4.5B Q3 '22: 3.6B Q4 '22: 3.7B Q1 '23: 3.8B Q2 '23: 3.8B Q3 '23: 3.7B Q4 '23: 3.7B Q1 '24: 3.6B Q2 '24: 3.7B Q3 '24: 3.7B Q4 '24: 3.8B Q1 '25: 3.8B Q2 '25: 3.7B Q3 '25: 3.6B Q4 '25: 3.7B Q1 '26: 3.6B Q2 '26: 3.6B Q3 '26: 3.6B Q4 '26: 3.6B Q1 '27: 3.7B Q2 '27: 3.8B Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Gross Profit TTM

0 900M 1.8B 2.7B Q3 '22: 2B Q4 '22: 2B Q1 '23: 2.1B Q2 '23: 2.1B Q3 '23: 2.1B Q4 '23: 2.1B Q1 '24: 2.1B Q2 '24: 2.2B Q3 '24: 2.3B Q4 '24: 2.3B Q1 '25: 2.4B Q2 '25: 2.3B Q3 '25: 2.3B Q4 '25: 2.4B Q1 '26: 2.4B Q2 '26: 2.4B Q3 '26: 2.5B Q4 '26: 2.5B Q1 '27: 2.6B Q2 '27: 2.6B Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Operating Income TTM

0 250M 500M 750M Q3 '22: 555.1M Q4 '22: 561M Q1 '23: 577M Q2 '23: 567.1M Q3 '23: 542M Q4 '23: 510.9M Q1 '24: 491M Q2 '24: 449.7M Q3 '24: 448.6M Q4 '24: 448.8M Q1 '25: 421M Q2 '25: 389M Q3 '25: 384.1M Q4 '25: 460.7M Q1 '26: 449M Q2 '26: 515.2M Q3 '26: 549.3M Q4 '26: 592M Q1 '27: 638.5M Q2 '27: 642.7M Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Net Income TTM

-600M 0 600M 1.2B 1.8B Q3 '22: 557.7M Q4 '22: 492.7M Q1 '23: 488.5M Q2 '23: 517.6M Q3 '23: 479.4M Q4 '23: 449.7M Q1 '24: 468.2M Q2 '24: 344.8M Q3 '24: 333.9M Q4 '24: 311.3M Q1 '25: 239.7M Q2 '25: 1.5B Q3 '25: 1.5B Q4 '25: 1.5B Q1 '26: 1.5B Q2 '26: 286.7M Q3 '26: 357.6M Q4 '26: 424M Q1 '27: 456.2M Q2 '27: -104.7M Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Cost of Revenue TTM

0 600M 1.2B 1.8B Q3 '22: 1.6B Q4 '22: 1.6B Q1 '23: 1.7B Q2 '23: 1.7B Q3 '23: 1.6B Q4 '23: 1.6B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.5B Q4 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.4B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '26: 1.1B Q4 '26: 1.1B Q1 '27: 1.1B Q2 '27: 1.1B Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Operating Cash Flow TTM

0 300M 600M 900M Q3 '22: 783.5M Q4 '22: 750.5M Q1 '23: 675.3M Q2 '23: 523.5M Q3 '23: 440.4M Q4 '23: 391.2M Q1 '24: 446.9M Q2 '24: 540.5M Q3 '24: 604.3M Q4 '24: 597.1M Q1 '25: 622.2M Q2 '25: 567.4M Q3 '25: 515.2M Q4 '25: 531.4M Q1 '26: 453.2M Q2 '26: 312.1M Q3 '26: 341M Q4 '26: 386.2M Q1 '27: 505.3M Q2 '27: 799.1M Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Free Cash Flow TTM

0 300M 600M 900M Q3 '22: 740.4M Q4 '22: 704.4M Q1 '23: 625.3M Q2 '23: 470.3M Q3 '23: 389.1M Q4 '23: 348M Q1 '24: 411.8M Q2 '24: 506.8M Q3 '24: 565.5M Q4 '24: 555.1M Q1 '25: 579.8M Q2 '25: 523.3M Q3 '25: 477.9M Q4 '25: 497.8M Q1 '26: 419.8M Q2 '26: 287.1M Q3 '26: 315.2M Q4 '26: 360.9M Q1 '27: 480.5M Q2 '27: 773.1M Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q1 '21: 251.7M Q2 '21: 251.2M Q3 '21: 252.8M Q1 '22: 254.3M Q2 '22: 254.2M Q3 '22: 254.5M Q1 '23: 252.8M Q2 '23: 250.7M Q3 '23: 248.9M Q1 '24: 248.7M Q2 '24: 249M Q3 '24: 249.7M Q1 '25: 247.4M Q2 '25: 246.4M Q3 '25: 246.9M Q1 '26: 246.2M Q2 '26: 239.6M Q3 '26: 240.4M Q1 '27: 236.9M Q2 '27: 233M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26 Q2 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.50 0.00 2.50 5.00 7.50 Q3 '22: 2.21 Q4 '22: 1.95 Q1 '23: 1.94 Q2 '23: 2.06 Q3 '23: 1.91 Q4 '23: 1.80 Q1 '24: 1.88 Q2 '24: 1.39 Q3 '24: 1.35 Q4 '24: 1.25 Q1 '25: 0.96 Q2 '25: 6.12 Q3 '25: 5.98 Q4 '25: 6.09 Q1 '26: 6.13 Q2 '26: 1.16 Q3 '26: 1.46 Q4 '26: 1.76 Q1 '27: 1.91 Q2 '27: -0.48 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.